Shark Cartilage 750mg Capsules
Natural health product licensed in Canada
- Other names
- Shark Cartilage, Super Shark Capsules, Super Shark Cartilage Capsules
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80083280
- Status
- Active licence
- Licence date
- 19 February 2018
- Revision date
- 2 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cartilage de requin Source : Requin - Cartilage Potency : 112.5 milligramme Calcium | 750 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 3 Tous les jours |
Uses authorised in Canada
Source of calcium which helps in the development and maintenance of bones and teeth. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). A natural source of Calcium for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Hypersensitivity (ie. allergy) to shark cartilage or any of its ingredients including sulphur, glucosamine and chondroitin has been known to occur; in which case, discontinue use. Consult a health care practitioner prior to use if you are pregnant and/or breastfeeding. Some people may experience taste disturbances, gastrointestinal disturbances (eg. nausea, vomiting, flatulence and constipation), confusion, decreased muscle strength, decreased sensation, weakness, dizziness, fatigue, increased or decreased blood sugar levels, hypercalcemia, low blood pressure, elevated liver enzymes and/or liver damage; in which case, discontinue use. Consult a healthcare practitioner prior to use if you have cardiovascular disease; peripheral vascular disease; liver dysfunction or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine); hypoglycaemia; diabetes; hypercalcemia; renal disease or are at risk of developing kidney stones; cardiac arrhythmias; if you are recovering from surgery or trauma; or if you are taking thalidomide or other anti-angiogenic agents.
Source
Official Health Canada record, licence 80083280
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.